Corrigendum to "The Utility of Ovotransferrin and Ovotransferrin-Derived Peptides as Possible Candidates in the Clinical Treatment of Cardiovascular Diseases"

Oxid Med Cell Longev. 2018 Dec 13:2018:1897257. doi: 10.1155/2018/1897257. eCollection 2018.

Authors

Shuang Chen¹, Hongmei Jiang¹, Hanhui Peng¹, Xiaosong Wu¹, Jun Fang^{1

2

3}

Affiliations

¹ College of Bioscience and Biotechnology and College of Animal Science and Technology, Hunan Agricultural University, Changsha 410128, China.
² Hunan Province University Key Laboratory for Agricultural Biochemistry and Biotransformation, Hunan Agricultural University, Changsha 410128, China.
³ Hunan Co-Innovation Center for Utilization of Botanical Functional Ingredients, Changsha 410128, China.

Abstract

[This corrects the article DOI: 10.1155/2017/6504518.].

Publication types

Published Erratum